Sumavel DosePro (sumatriptan injection) Approved by FDA for Acute Migraine and Cluster Headache: First Product Featuring Novel DosePro Needle-Free Delivery System
Sumavel DosePro (sumatriptan injection) Approved by FDA for Acute
Migraine and Cluster Headache: First Product Featuring Novel DosePro
Needle-Free Delivery System
July 16, 2009
SAN DIEGO, July 16 /PRNewswire/ -- Zogenix, Inc., a privately held
pharmaceutical company, today announced that it has received approval
from the U.S. Food and Drug Administration (FDA) for its New Drug
Application (NDA) for Sumavel DosePro (sumatriptan injection)
needle-free delivery system to treat acute migraine, with or without
aura, and cluster headache. Sumavel DosePro is a first-of-its-kind
needle-free delivery system for subcutaneous sumatriptan, a treatment
that provides migraine relief within 10 minutes for some patients.
Migraine and Cluster Headache: First Product Featuring Novel DosePro
Needle-Free Delivery System
July 16, 2009
SAN DIEGO, July 16 /PRNewswire/ -- Zogenix, Inc., a privately held
pharmaceutical company, today announced that it has received approval
from the U.S. Food and Drug Administration (FDA) for its New Drug
Application (NDA) for Sumavel DosePro (sumatriptan injection)
needle-free delivery system to treat acute migraine, with or without
aura, and cluster headache. Sumavel DosePro is a first-of-its-kind
needle-free delivery system for subcutaneous sumatriptan, a treatment
that provides migraine relief within 10 minutes for some patients.
Comentarios
Publicar un comentario